A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 17/00 (2006.01) A61P 19/00 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2730674
The present invention relates to suppression of TNF-alpha activity with mammalbeta defensins, which has utility in the treatment of pathological conditions associated with tumor necrosis factor alpha.
L'invention se rapporte à la suppression de l'activité TNF-alpha au moyen de bêta-défensines de mammifères, utilisée pour traiter des états pathologiques associés au facteur de nécrose tumorale alpha.
Andersen Birgitte
Brinch Karoline Sidelmann
Kjaer Tanja Maria Rosenkilde
Kjaerulff Soeren
Kruse Thomas
Dimock Stratton Llp
Novozymes Adenium Biotech A/s
LandOfFree
Treatment of inflammatory diseases with mammal beta defensins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of inflammatory diseases with mammal beta defensins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inflammatory diseases with mammal beta defensins will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1865112